The glucocerebrosidase mutations and uric acid levels in Parkinson’s disease: A 3-years investigation of a potential biomarker”

BACKGROUND: Blood uric acid level indicates an emerging biomarker in Parkinson's disease (PD). This study aimed to evaluate longitudinal uric acid levels among different kinds of glucocerebrosidase (GBA) mutations and to compare it among sporadic PD, genetic cohort Parkinson's disease (GEN...

Descripción completa

Detalles Bibliográficos
Autores principales: Mozafar, Mehrdad, Kazemian, Sina, Hoseini, Elahe, Mohammadi, Mohammad, Alimoghadam, Rojina, Shafie, Mahan, Mayeli, Mahsa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798165/
https://www.ncbi.nlm.nih.gov/pubmed/36590455
http://dx.doi.org/10.1016/j.prdoa.2022.100177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9798165/
https://www.ncbi.nlm.nih.gov/pubmed/36590455
http://dx.doi.org/10.1016/j.prdoa.2022.100177

Ejemplares similares